BMAL1 and breast carcinoma: Together, these results show that melatonin maintained BMAL1 expression by inhibiting the expression of LDH-A to prevent hypoxia-induced acidosis in MCF-7 and MDA-MB-231 breast cancer cells (Figure 5h).